Literature DB >> 12475992

Constitutive DNase I hypersensitivity of p53-regulated promoters.

Corey D Braastad1, Zhiyong Han, Eric A Hendrickson.   

Abstract

The ability of p53 to alter, at the transcriptional level, the gene expression of downstream targets is critical for its role as a tumor suppressor. Most models of p53 activation postulate the stepwise recruitment by p53 of coactivators, histone acetyltransferases, and/or chromatin remodeling factors to a promoter region to facilitate the subsequent access of the general transcriptional machinery required for transcriptional induction. We demonstrate here, however, that the promoter regions for the p53 target genes, p21, 14-3-3sigma, and KARP-1, exist in a constitutively open conformation that is readily accessible to DNase I. This conformation was not altered by DNA damage or by whether p53 was present or absent in the cell. In contrast, p53 response elements, which resided outside the immediate promoter regions, existed within DNase I-resistant chromatin domains. Thus, p53 activation of downstream target genes occurs without p53 inducing chromatin alterations detectable by DNase I accessibility at either the promoter or the response element. As such, these data support models of p53 activation that do not require extensive chromatin alterations to support cognate gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475992     DOI: 10.1074/jbc.M204256200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The p53 transcriptional synapse: activation on demand.

Authors:  Genrich V Tolstonog; Wolfgang Deppert
Journal:  Nat Struct Mol Biol       Date:  2009-09       Impact factor: 15.369

2.  UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer.

Authors:  Jianhua Yu; Lawrence Shi; Weiguo Lin; Baochun Lu; Yunfeng Zhao
Journal:  Biochem Pharmacol       Date:  2019-12-05       Impact factor: 5.858

Review 3.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

4.  Human U2 snRNA genes exhibit a persistently open transcriptional state and promoter disassembly at metaphase.

Authors:  Thomas Pavelitz; Arnold D Bailey; Christopher P Elco; Alan M Weiner
Journal:  Mol Cell Biol       Date:  2008-03-31       Impact factor: 4.272

5.  Role of p53 serine 46 in p53 target gene regulation.

Authors:  Leonie Smeenk; Simon J van Heeringen; Max Koeppel; Bianca Gilbert; Eva Janssen-Megens; Hendrik G Stunnenberg; Marion Lohrum
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

6.  Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.

Authors:  Neil T Pfister; Vitalay Fomin; Kausik Regunath; Jeffrey Y Zhou; Wen Zhou; Laxmi Silwal-Pandit; William A Freed-Pastor; Oleg Laptenko; Suat Peng Neo; Jill Bargonetti; Mainul Hoque; Bin Tian; Jayantha Gunaratne; Olav Engebraaten; James L Manley; Anne-Lise Børresen-Dale; Paul M Neilsen; Carol Prives
Journal:  Genes Dev       Date:  2015-06-16       Impact factor: 11.361

7.  Rotational positioning of nucleosomes facilitates selective binding of p53 to response elements associated with cell cycle arrest.

Authors:  Feng Cui; Victor B Zhurkin
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

8.  p53 binding sites in normal and cancer cells are characterized by distinct chromatin context.

Authors:  Feifei Bao; Peter R LoVerso; Jeffrey N Fisk; Victor B Zhurkin; Feng Cui
Journal:  Cell Cycle       Date:  2017-09-28       Impact factor: 4.534

9.  Tumor suppressor p53: from engaging DNA to target gene regulation.

Authors:  Morgan A Sammons; Thuy-Ai T Nguyen; Simon S McDade; Martin Fischer
Journal:  Nucleic Acids Res       Date:  2020-09-18       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.